NASDAQIndustrialsIntegrated Freight & LogisticsSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Raise equity capital | A supporting condition in CALLAN JMB INC's published investment case. The stated target is Raise at least $5 million in equity by 2026-Q3. | Improving | Fail to raise $5M equity by 2026-Q3 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve cash from operations | A primary condition in CALLAN JMB INC's published investment case. The stated target is Positive cash from operations by 2027-Q2. | Improving | Cash flow remains negative beyond 2027-Q2 | Cash from operations: $-396,063 FY2026-Q2; GAAP. Published target: Positive cash from operations by 2027-Q2. The stored target says 2027-Q2; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 14, 2026-396,063 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Resolve Nasdaq listing deficiencies | Callan JMB is working to fix its Nasdaq listing problems and improve its operating income. | Improving | Nasdaq delisting or failure to cure deficiencies by 2026-Q3 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reduce operating losses | Callan JMB is working to fix its Nasdaq listing problems and improve its operating income. | Intact | Operating loss remains worse than -$1.7M beyond 2026-Q4 | Operating income: $-1.347M FY2026-Q2; GAAP. Published target: Operating loss narrows to less than -$1.0M by 2026-Q4. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 14, 2026-1,346,646 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1996bd0f-ab01-43c1-8cd0-e953cae43e50. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making business with a volatile management profile, rather than an established compounder. The long-term thesis is in a watch state, and recent performance remains well below its industry cohort.
The valuation evidence describes CJMB as cheap versus peers, but confidence in that comparison is low. The snapshot gives little detail on what earnings or growth the market expects, so the expectations gap is unclear; low fragility means no listed fragility gates have been triggered.
Near term, fundamentals remain weak, with improving operating income and cash from operations still priorities to watch. The recent acquisition announcements add activity, but the evidence does not show their financial effect; Nasdaq listing compliance is also an unresolved concern.
Over the next one to three years, the thesis depends on better operating income and cash generation, alongside progress on listing compliance. Sector signals matter too: continued strength among UPS, FDX, and EXPD could support the Industrials backdrop, while weaker guidance or GDP growth below 2% could add pressure.
CJMB’s low peer valuation is set against meaningful business and listing risks, and the evidence does not yet show a clear improvement in its financial trajectory. The multi-year view hinges on execution, compliance, and a supportive sector backdrop. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.